Clinical Trials Logo

Filter by:
NCT ID: NCT00542815 Completed - Clinical trials for Chronic Kidney Disease

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Start date: November 2007
Phase: Phase 3
Study type: Interventional

This is a PIII multi-center, open-label, flexible dose, long-term safety study, that in conjunction with the E07(NCT00416520), E08(NCT00542386) and E09(NCT00451295) studies will allow exposure to MCI-196 for up to 52 weeks

NCT ID: NCT00542386 Completed - Clinical trials for Chronic Kidney Disease

A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia

Start date: December 2007
Phase: Phase 3
Study type: Interventional

This is a phase III multi-centre study in two periods: the first period is a phosphate binder and lipid lowering drugs washout for 8 weeks, the second period is a double-blind, randomised, parallel group, fixed dose, for 12 weeks.

NCT ID: NCT00542295 Completed - Clinical trials for Irritable Bowel Syndrome

Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome

Start date: July 2007
Phase: Phase 4
Study type: Interventional

To assess the effectiveness of alverine citrate and simeticone on IBS symptoms according to the latest recommended design

NCT ID: NCT00541658 Completed - Clinical trials for Postmenopausal Osteoporosis

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to study the efficacy of a 35 mg delayed release weekly dosing regimen as compared to the standard daily dosing regimen of risedronate 5 mg daily.

NCT ID: NCT00538785 Completed - Clinical trials for Congenital Heart Disease

A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease

Start date: October 2005
Phase: Phase 2
Study type: Interventional

The primary goal was to describe the safety of the investigational product when given monthly to prevent serious respiratory infection among children with significant heart disease.

NCT ID: NCT00537914 Completed - Clinical trials for Small for Gestational Age

Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

Start date: February 6, 2008
Phase: Phase 4
Study type: Interventional

This study is performed to investigate the long-term safety, in particular the diabetogenic potential and immunogenicity of rhGH therapy in short children born small for gestational age (SGA).

NCT ID: NCT00536913 Completed - Asthma Clinical Trials

Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma

Spacer
Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare Symbicort pMDI with and without spacer in terms of steroid potency, improvement of lung function and asthma symptoms in children with asthma (6-11 years).

NCT ID: NCT00536731 Completed - Bronchial Asthma Clinical Trials

Symbicort Rapihaler Therapeutic Equivalence Study

ESTHER
Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of the this study is to evaluate the efficacy and safety of 2 actuations Symbicort®pMDI® 40/2.25 μg twice daily compared with1 inhalation Symbicort Turbuhaler® 80/4.5 μg twice daily and 1 inhalation Pulmicort®Turbuhaler® 100 μg twice daily for 6 weeks.

NCT ID: NCT00535860 Completed - Osteoporosis Clinical Trials

Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis

Start date: April 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the clinical efficacy, safety, and tolerability of ViaDerm-shPTH [1-34] transdermal delivery in comparison to subcutaneous injection of rhPTH[1-34] following 3-month treatment in postmenopausal women with Osteoporosis

NCT ID: NCT00535756 Completed - Clinical trials for Pancreatic Insufficiency

Creon After Pancreatic Surgery

Start date: April 2008
Phase: Phase 4
Study type: Interventional

This study will provide efficacy data for Creon 25000 MMS in PS patients as well as long-term safety data. During the long-term treatment with Creon 25000 nutritional parameters will be assessed and correlated with CFA